ContentslistsavailableatScienceDirect
Toxicology
Reports
j o u r n al ho me p ag e : w w w . e l s e v i e r . c o m / l o c a t e / t o x r e p
Sub-chronic
exposure
to
fipronil
induced
oxidative
stress,
biochemical
and
histopathological
changes
in
the
liver
and
kidney
of
male
albino
rats
Abdel-Tawab
H.
Mossa
a,∗,
Eman
S.
Swelam
b,
Samia
M.M.
Mohafrash
a aEnvironmentalToxicologyResearchUnit(ETRU),PesticideChemistryDepartment,NationalResearchCentre,33BohouthStreet,Dokki,Giza,Egypt
bEconomicEntomologyandPesticidesDepartment,FacultyofAgriculture,CairoUniversity,Egypt
a
r
t
i
c
l
e
i
n
f
o
Articlehistory: Received1October2014
Receivedinrevisedform25January2015 Accepted11February2015
Availableonline19February2015 Keywords: Fipronil Rats Liver Kidney Oxidativestress Histopathology
a
b
s
t
r
a
c
t
Fipronil(FPN)isabroad-spectrumN-phenylpyrazoleinsecticideandhasbeenusedin
agricultureandpublichealthsincethemid-1990s.Thepresentstudywasdesignedto
inves-tigatetheadverseeffectsofsub-chronicexposuretotheFPNontheliverandkidneyofmale
ratsatthreeconcentrations0.1,1and10mg/Lindrinkingwaterfor45days.Serum
aspar-tateaminotransferases(AST),alanineaminotransferases(ALT),alkalinephosphatase(ALP),
andlactatedehydrogenase(LDH)activityandlevelsofuricacid,creatinineandtotal
pro-teinweresignificantlyincreasedinFPN-treatedrats.Oxidativestressbiomarkerssuchas
superoxidedismutase(SOD),catalase(CAT),glutathioneperoxidase(GPx),
glutathione-S-transferase(GST)andglutathionereduced(GSH)weresignificantlydecreased,whilelipid
peroxidation(LPO)wassignificantlyincreasedintreatingratsinaconcentrationdependent
manner.FPNcausedhistopathologicalalterationsinliverandkidneyofmalerats.Fromour
results,itcanbeconcludedthatFPNinducedlipidperoxidation,oxidativestress,liver,and
kidneyinjuryinrats.Thesepathophysiologicalchangesinliverandkidneytissuescouldbe
duetothetoxiceffectofFPNthatassociatedwithagenerationoffreeradicals.
©2015TheAuthors.PublishedbyElsevierIrelandLtd.Thisisanopenaccessarticleunder
theCCBYlicense(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Fipronil (FPN,
5-amino-1-(2,6-dichloro-4-(trifluoro-methylphenyl)-4-(trifluoro-methylsulfinyl)
pyrazole-3-carbonitrile)isaphenylpyrazoleinsecticidethatis
exten-sivelyusedtocontrolinsectsindifferentcerealcropsand
inpublichealthmanagement[1].Itismoreeffectivethan
organophosphate,carbamateandpyrethroidsinsecticides
against several species of Lepidoptera, Orthoptera and
Coleopteran[2,3].Currently,exposuretophenylpyrazole
pesticidesisaglobalpublichealthissueandconcernsare
∗ Correspondingauthor.Tel.:+20233371211;fax:+20233370931. E-mailaddress:abdeltawab.mossa@yahoo.com(A.-T.H.Mossa).
increasedregardingtherelativesafetyofthesepesticide
groups because of widespread use, their toxicity, and
releasesintotheenvironment.
FPNisneurotoxictoinsectsandtheprimarymechanism
ofactionreferstoblocksiontropicgamma-aminobutyric
acidreceptor(GABAR)ofthecentralnervoussystemthat
causeshyper-excitationatlowdosesandconvulsions
lead-ingtoinsectdeathathighdoses[4].FPNismoretoxicto
insectsthanmammals[5]andhasmoderatelyacuteoral
toxicityLD50’srangingfrom40to100mg/kgbodyweight
inratsandmice[3,6].Therefore, completeselectivityof
pesticidesisdifficultandmostofthepesticidesaretoxicto
non-targetorganisms,includinghumans[7].
FPN is a stronguncoupler of oxidative
phosphoryla-tionatrelativelylowconcentrations inSH-SY5Yhuman
http://dx.doi.org/10.1016/j.toxrep.2015.02.009
2214-7500/©2015TheAuthors.PublishedbyElsevierIrelandLtd.ThisisanopenaccessarticleundertheCCBYlicense(http://creativecommons.org/ licenses/by/4.0/).
neuroblastomacellsinvitroandinducedneuronal
apopto-sis,mediatedbyincreasedgenerationofreactiveoxygen
species(ROS)[8].BothHepG2cellsand primaryhuman
hepatocytesaresensitivetothecytotoxiceffectsofFPN[9].
FPNanditsmetabolitesinducedcytotoxicityinepithelial
model Caco-2 cells at micromolar concentration
expo-sure[8]. FPN inhibitsDNA and protein synthesis in rat
neuronotypicpheochromocytomaPC12cellsandinduced
oxidativestressmorethanchlorpyrifos[10].FPNcauses
endocrinedisruptionandadversereproductiveeffectsin
femalerats[11],elevationinlipidperoxidation(LPO)and
decreaseinthelevelsofglutathione(GSH)atthedosageof
0.5mg/kg/dayfor98daystobuffalocalves[12]andaltered
SODandCATactivitiesintheliverofCyprinuscarpio[13].It
decreasedtotalthyroxine(T4),increasedhepaticenzymes
inplasmaoffemalerat[14],andcausedacutehuman
poi-soning[15,16].
Liverandkidneyarethemostsensitiveandmain
tar-getorgansofpesticidetoxicityanddamage[17],theyplay
amajor rolein thebiotransformation ofpesticides.The
sensitivityof thesetissuestothis stresstopesticidesis
afunctionof thedisturbedbalancebetweenthedegree
ofoxidativestressandtheantioxidantcapability[17,18].
Previousstudiesshowthatpesticidesalterenzymaticand
non-enzymaticantioxidantandinducedoxidativestressin
animalsthatwasinvestigatedasapotentialmechanismof
pesticidetoxicity[16,18,19].Ithasbeenreportedthat
pro-longedexposuretolowdosesoffipronilleadstooxidative
stressinserumofpregnantratsandtheiroffspring[20].
Pesticide formulations are complex mixtures that
contain, besides the active ingredient(s), several other
components,suchassolvent,wetting,emulsifyingagents,
andadditives;thereforethetoxicityinformationonactive
ingredientsaloneisnotsufficienttoevaluatetheadverse
health effects of commercial pesticides. Therefore, the
WHOemphasizedthenecessityofevaluatingtoxichazard
oftheformulatedpesticides[21].Overthelastdecade,the
usageofFPNhasincreasedconsiderablyandinformation
onadversehealtheffectsisverylimited.Tothebestofour
knowledge,therearenopublishedstudiesthathave
exam-inedtheeffectofformulatedFPNonoxidant/antioxidant
statusandtheliverandkidneyfunctionbiomarkersinmale
rats.Therefore,thisstudyaimedtoevaluatetheadverse
effectsofsub-chronicexposuretoformulatedFPNon
oxi-dant/antioxidantstatusandliverandkidneybiomarkersof
malerats.
2. Materialsandmethods
2.1. Animalsandmanagement
Malealbinoratsweighing105±5gwereprocuredfrom
theAnimalBreedingHouseoftheNationalResearchCentre
(NRC),Dokki,Giza,Egypt.Ratswerehousedin
polypropyl-enecages(sixratsineach),withfreeaccessstandardpellet
diet,wateradlibitum,understandardizedhousing
condi-tions(12hlight/darkcycle,temperature(23±2◦C)anda
minimumrelativehumidityof48%inthelaboratory.The
ratswereacclimatizedfor1weekbeforethestartofthe
experiment.Alltheratswerekeptaccordingtothe
guide-linesandwelfareregardinganimalprotectionapprovedby
NRCLocalEthicalReviewCommitteeandwasconducted
inaccordancewiththe“GuidefortheCareandUseof
Lab-oratoryAnimals”.
2.2. Chemicalsandreagents
Fipronil (Insecto SC 5%) is a product of BASF
Com-pany and manufactured by, Sinochem Group Ningbo
TechnicalCo.,Ltd.,China.Theassaykitsusedfor
biochem-ical measurementsof aspartate aminotransferases (AST,
EC2.6.1.1.), alanineaminotransferases (ALT, EC2.6.1.2),
alkalinephosphatase(ALP,EC3.1.3.1),lactate
dehydroge-nase (LDH,EC1.1.1.27), superoxidedismutase(SOD, EC
1.15.1.1), catalase(CAT, EC1.11.1.6),glutathione
perox-idase (GPx, EC 1.11.1.9), glutathione-s-transferase (GST,
EC2.5.1.13),glutathionereduced(GSH),lipidperoxidation
(LPO),albumin,uricacidandcreatininewerepurchased
fromBiodiagnosticCompany,Dokki,Giza,Egypt.Allother
chemicalswereofreagentgradesandwereobtainedfrom
reputedcompanies.
2.3. Experimentaldesign
Rats were randomly divided into four experimental
groups,sixrats.GroupI,receivedwaterandservedasa
con-trol.Theremainingthreegroups(II,IIIandIV)receivedFPN
indrinkingwateratconcentrations0.1,1.0and10mg/L
for45consecutivedays.TheconcentrationsofFPNwere
calculateddependingonthepercentageofactive
ingredi-entsofcommercialformulationofFPN.Concentrationsof
FPNwerefreshlypreparedandbodyweightswere
moni-toredweeklyduringtheexperimentalperiod.Allratswere
observedfor signsoftoxicity andmortalitydailyfor 45
days.
Theconcentrationsusedinthisstudyrepresent2.0,0.2
and0.02mg/kgb.wt.ofFPN,basedonaveragewater
con-sumptions and body weights of treated rats.The lower
concentrationofFPNrepresentsthedoseofnoobservable
adverseeffectlevel(NOAEL)ofhuman[22]with
descen-ding concentrationlevelsby 10-foldinterval, i.e.,1 and
10mg/L.
2.4. Bloodandtissuesamples
Attheendoftheexperimentalperiod,ratswerefasted
overnightandbloodsampleswerecollectedbypuncturing
theretero-orbitalvenousplexusoftheanimalswithafine
sterilizedglasscapillary,thenratsweresacrificedby
cer-vicaldislocation.Bloodsampleswerelefttoclotinclean
drytubesandcentrifugedat3000rpm(600xg)for10min
at4◦CusingHeraeusLabofuge400R(KendroLaboratory
ProductsGmbH,Germany)toobtainthesera.Serum
sam-pleswerestoredat−20◦Cforfurtherbiochemicalanalysis,
suchasAST,ALT,ALPandLDH.
Liverandkidneywereexcisedimmediatelyafter
sacri-ficed,cleanedinsalineandweighed.Smallpiecesofeach
liverandkidneywerecutandkeptin10%naturalformalin
forhistopathologicalstudy.Theotherportionsofliverand
kidneywerehomogenizedin10%(w/v)icecold100mM
phosphatebuffer(pH7.4)andcentrifugedat10,000rpm
obtainedandusedforoxidativestressbiomarkersstudies
(SOD,CAT,GPx,GSH,LPO)andtotalprotein.
2.5. Serumbiochemicalparameters
2.5.1. Liverandkidneyfunctionbiomarkers
SerumASTandALTweredeterminedaccordingtothe
methods ofReitman and Frankel[23],ALP accordingto
Youngetal.[24],LDHasanindicatorofnecroticcelldeath
wasdeterminedaccordingtoVassault[25],albumin,uric
acidandcreatinineaccordingtoWestgard andPoquette
[26],Tietzetal.[27]andTietz[28],respectively.Allserum
biomarkerswereperformedaccordingtothedetailsgiven
inBiodiagnostickit’sinstructions(BiodiagnosticCompany,
Dokki,Giza,Egypt).
2.5.2. Oxidativestressbiomarkersinliverandkidney
DeterminationofSOD,CAT,GPx,GST,GSHandlipid
per-oxidation(LPO)wereperformedaccordingtothedetails
giveninBiodiagnostickit’sinstructionsandtheprincipals
belowofdifferentmethodsaregivenforeachconcerned
biochemicalparameter.
SOD was determined according to the method of
Nishikimi et al. [29]. The method based on the ability
ofSODenzymetoinhibitthephenazine
methosulphate-mediatedreductionofnitrobluetetrazoliumdye.Briefly,
0.05ml sample was mixed with 1.0ml buffer (pH 8.5),
0.1mlnitrobluetetrazolium(NBT)and0.1mlNADH.The
reactionwasinitiatedbyadding0.01mlphenazine
metho-sulphate(PMs),andthenabsorbancewasreadat560nm
for5min.SODactivitywasexpressedasunits/mgprotein.
CAT was determined according to the method of
Abei [30]. The method is based on the decomposition
of H2O2 by catalase. The sample containing catalase
is incubated in the presence of a known
concen-tration of H2O2. After incubation for exactly 1min,
the reaction is quenched with sodium azide. The
amount of H2O2 remaining in the reaction mixture is
then determined by the oxidative coupling reaction of
4-aminophenazone (4-aminoantipyrene, AAP) and
3,5-dichloro-2-hydroxybenzenesulfonic acid (DHBS) in the
presenceofH2O2andcatalyzedbyhorseradishperoxidase
(HRP).Theresultingquinoneiminedye
(N-(4-antipyrl)-3-chloro-5-sulfonate-p-benzoquinonemonoimine) is
mea-suredat510nm.CATactivitywasexpressedasmol/mg
protein.
GSTwasdeterminedaccordingtothemanufacturer’s
instructionsreferredtoHabigetal.[31].Themethodwas
basedontheconjugationof1-chloro-2,4-dinitrobenzene
(CDNB)withreducedglutathione(GSH)inareaction
cat-alyzed byGST. GST activitywasexpressedasmol/mg
protein.
GPxwasdeterminedspectrophotometricallyaccording
tothemethodofPagliaandValentine[32].The
estima-tionof GPxactivitywasbasedontheoxidation ofGSH
andNADPHusingglutathionereductase(GR)and
measur-ingthedecreaseinabsorbanceat340nmandexpressedin
units/mgprotein.
GSHlevelwasassessedspectrophotometrically
accord-ingtothemethodofBeutleretal.[33].Themethodwas
based on the reduction of 5,5-dithiobis(2-nitrobenzoic
acid)(DTNB)withglutathionetoproduceayellow
com-pound.Thereduced chromogendirectlyproportional to
GSHconcentrationanditsabsorbancecanbemeasuredat
405nm.GSHcontentwasexpressedinmol/mgprotein.
Lipidperoxidationwasestimatedbymeasuring
thio-barbituric acid reactive substances (TBARS) and was
expressedintermsofmalondialdehyde(MDA)contentby
acolorimetricmethodaccordingtoSatoh[34].TheMDA
valueswereexpressedasnmolesofMDA/gprotein.
Proteinconcentrationinhomogenatewasdetermined
accordingtothemethoddescribedbyLowryetal.[35].
2.5.3. Histopathologicalstudies
Liver and kidney were removed and dehydrated in
gradedserialofalcoholandembeddedinparaffinwax[36].
Fivemicrometerthicksectionswerecutand stainedby
hematoxylinandeosin(H&E).Oneslidewaspreparedfor
eachorgan;eachslidecontainedtwosectionsandtenfield
areaswereexaminedforhistopathologicalchanges. The
examinationwasdoneusing a light microscope
(Olym-pus BX50) witha digital camera (OlympusE-410). The
histopathological alterations in liver and kidney tissues
werescoredasfollows:normalappearance(−),mild(+),
moderate(++)andsevere(+++)[36].
2.5.4. Statisticalanalysis
Alldatawereexpressedasmean±standarderror(SE).
Datawerestatisticalanalyzedbyone-wayANOVA
analy-sisfollowedbyDuncan’stestusingSPSSversion17.0for
windowsandthedifferenceswerestatisticallysignificant
atp<0.05.
3. Results
3.1. Signsoftoxicity
Nomortalityoccurredduringtheexperimentalperiod.
Generally,signsoftoxicityincludedachangeinactivityand
abnormalgaitwereobservedinratsexposedto
concentra-tion10mg/LofFPNfromthesecondweek.
3.2. Bodyandrelativeorganweights
Dataoffinalbodyweightsandrelativeliverandkidney
weightsofmaleratssubjectedtodifferenttreatmentsare
showninFig.1.Aslightdecreaseinthebodyweightafter45
daysofFPNtreatmentwiththethreeconcentrations,
com-paredtocontrolgroup.Theweeklybodyweightgainwas
insignificantchangedbetweentreatments.Asobservedin
thecaseofrelativeliverandkidneyweights(Fig.1BandC),
bothorganweightswerefoundtohavesignificant
alter-ationsin rat exposed to 10mg/L ofFPN. Moreover,the
relativeliverandkidneyweightsofratexposedto1mg/L
and0.1mg/Lwerealteredslightly.
3.3. Serumbiochemicalparameters
Theactivityofserumenzymes;AST,ALT,ALPandLDH
wassignificantlyincreasedafter45daysofexposureto1
and10mg/LofFPNwhencomparedtothecontrolgroup
Table1
Theactivityofsomeenzymesintheseraofmaleratsexposedtothesub-lethalconcentrationsoffipronilfor45days.
Treatments AST(U/L) ALT(U/L) ALP(U/L) LDH(U/L)
I 52.98±0.76a 30.60±0.93a 60.24±0.98a 112.25±4.12a
II 54.76±0.53a 34.62±0.76b 64.81±1.11a 116.95±4.28a
III 58.50±0.54b 47.40±0.72c 70.01±1.74b 150.08±4.51b
IV 79.20±1.16c 63.10±1.23d 102.75±2.53c 202.70±6.79c
Eachvalueisameanofsixanimals±SE.Meanshavingthesamelettersarenotsignificantlydifferentfromeachother,p<0.05.I:controlgroup;II,IIIand IV:groups;animalthatreceived0.1,1.0and10.0mg/LofFPNrespectively.
theactivityofALTcomparedtountreatedone,whilethe
activitiesofAST,ALPandLDHhadnosignificantchanges.
AsshowninTable2thecomparativeanalysisoftotal
protein,uricacidandcreatinineingroupIVwas
signifi-cantlyincreased.Ontheotherhand,significantincreasein
totalproteinandcreatininewererecordedinratsexposed
0 50 100 150 200 250 300 I II III IV Bo dy w eigh t ( g) Groups a a a a
A
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 I II III IV Re la ve li ve r w ei g ht ( %) Group a a ab bB
0 0.2 0.4 0.6 0.8 1 1.2 I II III IV Rela v e kidn ey weig ht (% ) Group a a a bC
Fig.1.Bodyweight(A)andrelativeweightsofliver(B)andkidney(C)of maleratsexposed01,1.0and10.0mg/Loffipronil(groupsII,IIIandIV, respectively)for45daysindrinkingwaterandcontrolgroup(I).Values representedaremeans±SE.Meanshavingthesamelettersarenot signif-icantlydifferentfromeachother,p<0.05.Relativeorganweight=[organ weight/bodyweight]×100.
to1mg/LofFPN(groupIII).TheresultsrevealedthatFPN
changedserumbiomarkersinaconcentrationdependent
manner.
3.4. Oxidativestressbiomarkers
AsshowninTable3andFig.2,oxidativestress
biomark-ers;SOD,CAT,GST,GPx,GSHandLPOweredeterminedin
liverandkidneytissuesofmaleratsexposedto0.1,1and
10mg/LofFPNfor45days.Ratsexposedto1mg/LofFPN
(groupIII)showedsignificantchangesintheactivityofGPx,
GSHandLPOlevelinlivertissueandSOD,GST,GPx,GSH
activitiesandLPOlevelinkidneytissue.IngroupIV,rats
exposedto10mg/LofFPN,significantchangesinall
oxida-tivestressbiomarkers(SOD,CAT,GST,GPx,GSHandLPO)
wererecordedinbothorgans.Thepresentresultsrevealed
thatFPNcausedstatisticallysignificantchangesin
oxida-tivestressbiomarkersintheliverandkidneyhomogenates
inaconcentrationdependentmanner.
3.5. Histopathologicalobservations
Figs.3and4andTable4showhistopathological
alter-ationsandscoreintheliverandkidneyofmaleratsexposed
to0.1,1and10mg/LofFPNfor45dayscomparedto
con-trol. Liver sectionsin thecontrolrats(group I) showed
thenormalhistopathologicalstructureofthehepatic
lob-ule(Fig.3a).Severehistopathologicalalterations,including
degeneration,infiltration,inflammatorycells, cell
prolif-erationandfocalhepatichemorrhagewerenotedinthe
liverof maleratsexposedto10mg/LofFPN (groupIV)
(Fig.3b).Ratsexposedto1mg/LofFPN(groupIII)showed
degenerationof hepatocytesand portalinfiltrationwith
inflammatory cells (Fig.3c). Mild alterations, including,
congestion,vacuolizationandcysticdilation ofbileduct
werenotedintheliverofmaleratsexposedto0.1mg/Lof
FPN(groupII)(Fig.3d).
Lightmicroscopicofkidneysectionsinthecontrolrats
(groupI)showedthenormalhistopathologicalstructureof
renalparenchyma(Fig.4a).Severehistopathological
alter-ations, includingnecrosis,inflammatory cellinfiltration,
atrophyofglomerulartuft,vacuolation,focalhemorrhage
(Fig.4b)werenotedinthekidneyofmaleratsexposed
to10mg/Lof FPN(groupIV).Rats exposedto1mg/Lof
FPN (group III) showed vacuolation of epithelial lining
renal tubulesand focal hemorrhage (Fig.4c). Kidney of
ratsexposedto0.1mg/LofFPN(groupII)appearedas
nor-malcontrolwithmildvacuolationofepithelialliningrenal
Table2
Effectoffipronilonalbumin,totalprotein,uricacidandcreatininelevelsinseraofmalerats.
Treatments Totalprotein(g/dl) Albumin(g/dl) Uricacid(mg/dl) Creatinine(mg/dl)
I 6.79±0.21a 4.79±0.09a 6.31±0.28a 0.95±0.02a
II 7.21±0.19ab 4.78±0.06a 6.58±0.22ab 0.99±0.03a
III 7.52±0.16b 4.74±0.10a 7.02±0.31ab 1.18±0.04b
IV 8.51±0.32c 4.53±0.11a 7.25±0.16b 1.37±0.03c
Eachvalueisameanofsixanimals±SE.Meanshavingthesamelettersarenotsignificantlydifferentfromeachother,p<0.05.I:controlgroup;II,IIIand IV:groups;animalthatreceived0.1,1.0and10.0mg/LofFPNrespectively.
Table3
Effectoffipronilonoxidativestressbiomarkersinlivertissuesofmalerats. Treatments Oxidativestressbiomarker
SOD(U/mg protein) CAT(mol/mg protein) GST(mol/mg protein) GPx(U/mg protein) GSH(mol/mg protein) LPO(nmol/g protein) I 6.67±0.11b 13.85±0.25b 0.43±0.017b 7.78±0.34c 0.078±0.002c 74.25±2.44a II 6.82±0.14b 13.56±0.42b 0.42±0.007b 5.87±0.31b 0.076±0.002c 78.17±3.23ab III 6.86±0.23b 12.98±0.28b 0.41±0.004b 5.23±0.39b 0.071±0.0013b 87.62±2.56b IV 5.47±0.07a 7.91±0.26a 0.33±0.012a 3.52±0.27a 0.048±0.002a 111.76±4.21c
Eachvalueisameanofsixanimals±SE.Meanshavingthesamelettersarenotsignificantlydifferentfromeachother,p<0.05.I:controlgroup;II,IIIand IV:groups;animalthatreceived0.1,1.0and10.0mg/LofFPN,respectively.
Table4
Theseverityofthereactioninliverandkidneytissueofdifferentgroupsaccordingtothehistopathologicalalterations.
Histopathologicalalterations Treatments
I II III IV
Liver
Ballooningdegenerationofhepatocytes – + +++ +++
Congestionofcentralvein – + – –
Portalinfiltrationwithinflammatorycells – + ++ +++
Ovalcellsproliferation – – – ++
Focalhepatichemorrhage – – – ++
Cysticdilatationofbileduct – – – –
Kidneys
Focalnecrosisofrenaltubulesassociatedwithinflammatorycellsinfiltration. – – – +++
Vacuolationofepithelialliningrenaltubules. – + ++ +++
Focalrenalhemorrhage – – ++ ++
+++Severe;++moderate;+mild;–nil.I:controlgroup;II,IIIandIV:groupsreceivedFPNatconcentrationsof0.1,1.0and10.0mg/L. 4. Discussion
NomortalitywasobservedinratsexposedtotheFPN
at differentconcentrationsfor 45 days.While the
clini-calsignsrelatedtoFPN-treatment(group IV)includeda
changeinactivityandabnormalgaitwereobservedfrom
thesecondweek.ThepotentialforFPNtoinducespecific
neurotoxicitywasreportedbyotherstudiesinmice[37],
rats[38]andhuman[16].
Inthepresentstudy,exposureofrattotheFPNresulted
inaslightlyreducedbodyweightandsignificantelevation
inrelativeliverandkidneyweightsespeciallyathigh
con-centration(groupIV).Theslightdecreaseinbodyweight
maybeduetotheoxidativestressand neurotoxicityof
FPN,whiletheincreaseinrelativeliverandkidneyweights
couldbeattributedtotherelationshipbetweentheliver
weightincreaseandvarioustoxicologicaleffectsortothe
reduction in body weight gain of experimentalanimals
[17–19,39].FPNtreatmentcausedanincreaseinliverand
thyroidglandweightofrats[40].
The results of the present study indicate that
sub-chronicexposureto1and10mg/LofFPN(groupsIIIand
IV)causeliverand kidneydamage intreated rats
com-paredtocontrolasshownbyincreasesinserummarker
enzymesAST,ALT,ALPandLDHalongwithincreasesin
creatinine,uricacidandtotalproteinlevelsina
concen-trationdependentmanner.Liverenzymesinserum e.g.,
AST,ALT, ALP and LDH are mainly usedin the
evalua-tionofhepaticdamage.Transaminases(ASTandALT)play
animportantroleinaminoacidscatabolismand
biosyn-thesis.Theyareresponsiblefordetoxificationprocesses,
metabolismandbiosynthesisofenergeticmacromolecules
fordifferentessentialfunctions[41,42]andusedas
spe-cificindicatorsforliverdamage[43].Theincreaseinthese
enzymesmaybeduetoliverdysfunctionanddisturbance
inthebiosynthesisoftheseenzymeswithalterationinthe
permeability ofthelivermembrane takesplace [44].In
thecurrentstudy,theelevationinLDHactivityinserum
ofrat exposed toFPN maybedue tothehepatocelluar
necrosisandleakageof theenzymeintotheblood[45].
OraladministrationofFPNatdose0.5mgkg−1day−1for21
daysinducedsignificantincreasesinplasmaLDH,AST,acid
phosphatase, gamma-glutamyl transferase, total plasma
0 1 2 3 4 5 6 I II III IV S OD (U/mg pr ot e in ) Group c c b a SOD 0 2 4 6 8 10 12 I II III IV CAT (μmol/ mg pr otein) Group b b b a CAT 0 0.01 0.02 0.03 0.04 0.05 0.06 0.07 0.08 0.09 I II III IV GST (μmol/ mg protein) Group GST c b b a 0 1 2 3 4 5 6 I II III IV GP x ( U/ mg protein ) Group c b b a GPx 0 0.01 0.02 0.03 0.04 0.05 0.06 I II III IV GSH ( μm o l/ mg p ro tein) Group d c b a GSH 0 20 40 60 80 100 120 I II III IV LPO (n m ol/g pr ot e in ) Group a ab b c LPO
Fig.2.Oxidativestressbiomarkers;SOD,CAT,GPx,GST,GSH,LPOinkidneytissueofmaleratsexposedto01,1.0and10mg/Loffipronil(groupsII,IIIand IV,respectively)for45daysindrinkingwaterandcontrolgroup(I).valuesrepresentedaremeans±SE.Meanshavingthesamelettersarenotsignificantly differentfromeachother,p<0.05.
resultsaresupportedbyotherstudiesconductedonothers
insecticides[17,18,39,45,47,48].
Serumuricacidandcreatinineconcentrationswere
sig-nificantly increased in FPN-treated rats(group IV).The
increasedinuricacidmaybeduetodegradationofpurines
and pyrimidines or increase uric acid concentrationby
eitheroverproductionortheinabilityofexcretion[39,47]
andanelevationofcreatininelevelin theblood isthus
anindicationofimpairedkidneyfunction[49,50].In
addi-tion, the increase of total protein in FPN-treated rats
(groupsIIIand IV) maybedue to theliverand kidney
dysfunctions,partiallybecauseofthehighelevationofthe
serumenzymes[17,18,39].Otherinvestigationsshowedan
increaseofurea,creatinineandtotalproteinintheserumin
ratsexposedtodifferentpesticides[43,44,49].Ratorgans
affectedbychronicFPNexposureincludethethyroid,liver
andkidney[51].
ResultsrevealedthatFPNtreatmentcausedoxidative
stressintheliverandkidneyofmalerats,whichis
evi-dentfromthegenerationoflipidperoxidation(LPO).LPO
is knowntodisturbtheintegrityofcellularmembranes
andimplicatedinthepathogenesisofvariousliverand
kid-neyinjuries[52,53].Therefore,ithasusedasbiomarkers
of pesticides induced oxidative stresses [54] and
sug-gested as one of the molecular mechanisms involved
in pesticides-induced toxicity [55]. Increased levels of
malondialdehyde (MDA), a lipid peroxidation produced
in theliverand kidneyof FPN-treatedratsmaybe due
toincreased production ofreactiveoxygen metabolites,
especiallyhydroxylradicalsandalterantioxidantdefense
system [19]. Tukhtaev et al. [20] found that prolonged
exposureto low dosesof FPN increasedLPO inliver of
pregnantratsandtheiroffspring.Availablestudiesindicate
thatinsecticidesincreasedLPOinanimals[45,52,53].
FPN-treatment increased oxidative stress by altering
theenzymeactivitiesassociatedwithantioxidantdefense
mechanismsintheliverandkidneyofmalerats.Itcaused
decreasesintheactivityofantioxidantenzymesSOD,CAT,
GPxandGSTandlevelofGSHinaconcentrationdependent
Fig.3.PhotomicrographofliversectionsstainedbyH&Eforhistopathologicalchangesshowing:control(groupI)showing(A)thenormalhistopathological structureofhepaticlobule(H)(64×).10mg/LofFPN(groupIV)showing(B)ballooningdegeneration(D)ofhepatocytes,portalinfiltrationwithinflammatory (I)cellsandovalcellproliferation(400×)and(B1)showingballooningdegeneration(D)ofhepatocytesandfocalhepatichemorrhage(H)(400×).FPN at1.0mg/L(groupIII)showing(CandC1)degenerationofhepatocytesandportalinfiltrationwithinflammatorycells(400×).FPNat0.1mg/L(groupII) showing(D)congestion(C)ofcentralvein(400×)and(D1)cytoplasmicvacuolization(V)offocalhepatocytesandcysticdilationofbileduct(400×).
togethertopreventtheeffectofROS intissuesand are
activeinthedefenseagainstoxidativecellinjurybymeans
oftheirbeingfreeradicalscavengers[56].Therefore,SOD,
CATandGPxareconsideredfirstdefensesthatprotectcell
macromolecules fromoxidativedamage.In thisrespect,
SOD acceleratesthedismutationof superoxideanionto
lessreactivemolecule(H2O2)whichisrapidlyconvertedto
waterandoxygenbyCATandGPx[52,57].Inthepresent
study,thedecreasedinSOD,CATandGPxactivityinthe
liverandkidneyinratsexposedtoFPNcouldbedueto
excessproductionofO2•−whichrapidlyconvertedtoH2O2
by SODand towater byCATand GPx.Previousstudies
reportedthatpesticidese.g.chlorpyrifos,triazophosleads
todecreasein SOD,CATandGPxinliverand kidneyof
rats[17,18,21,45,52,53,57].Inagreementwithourstudies,
asignificantdecreaseinSODactivitywasobservedinliver
ofpregnantratsandtheiroffspringexposedtolowdoses
ofFPN[21],alsoSOD,CATandGPxactivityweredecreased
bydiazinontreatmentinmice[58].FPNcanberesponsible
forincreasesintheproductionofreactiveoxygenspecies
(ROS)incells,whichleadtoincreasedlipidperoxidation
levelsandoxidativestress[63].Ithasbeenreportedthat
FPNwasresponsibleforoxidativestressinC.carpio,which
wasevidentthroughalterationsonantioxidantenzymes
andincreasedlipidperoxidationlevels[59].
GSTconstituteafamilyofenzymesthatplayan
impor-tantrole inmetabolism,particularlyindetoxificationof
xenobiotic e.g. pesticides and intracellular transport of
metabolites[60].Theseenzymescatalyzetheconjugation
ofreactiveelectrophileswithglutathione(GSH),andhave
been implicated with the potential of forming reactive
intermediatesinparticularwhenGSHlevelsinthecellsare
attenuated,consequentlyresultingintoxicologicaleffects
[61,62].Inthepresentstudy,theactivityofGSTandthe
levelofGSHweresignificantlydecreasedinliverand
Fig.4. PhotomicrographofkidneysectionsstainedbyH&Eforhistopathologicalchangesshowing:control(groupI)showing(A)thenormal histopatholog-icalstructureoftheglomerular(G)andtubules(T)atthecortex(64×).10mg/LofFPN(groupIV)showing(B)focalnecrosis(N)ofrenaltubulesassociated withinflammatory(I)cellsinfiltrationaswellasatrophyofglomerulartuft(400×)and(B1)vacuolation(V)ofepithelialliningrenaltubulesandfocal hemorrhage(H)(400×).FPNat1.0mg/L(groupIII)showing(C)vacuolation(V)ofepithelialliningrenaltubulesandfocalhemorrhage(H)(400×).FPNat 0.1mg/L(groupII)showing(D)vacuolation(V)ofepithelialliningrenaltubules(400×).
inantioxidantenzymeactivitiesinliverandkidneytissues
wasduetocellularinjuryanddeathofhealthycellsthatare
abletorespondtotheoxidativeinsult.Inaddition,itmay
beduetotheinsufficientdetoxificationcapacityofFPNand
damagecausedbyreactiveoxygenspecies.FPNreduced
theactivityofGSTandGPxintadpolesoffrogs[60].
Sim-ilarsignificantdecreasedinGSTactivitywereobservedin
theliverofchlorpyrifostreatedrats[17].
The change in oxidative stress, liver and kidney
biomarkersinratsexposedtotheFPNcorroboratedthe
histopathologicallesionsobservedinthisstudy.The
his-tologicalobservationsofliverrevealseveredegeneration,
infiltration,inflammationandfocalhepatichemorrhage.In
kidneyseverenecrosis,inflammation,atrophyof
glomeru-lartuft,vacuolationandfocalhemorrhagewereobserved.
Theseobservationsindicatedmarkedchangesinthe
over-allhistoarchitectureofliverandkidneyinresponsetoFPN.
ThesechangescouldbeduetoFPNtoxiceffects
primar-ilybythegenerationofreactiveoxygenspecies causing
HistologicalobservationsontheliverandkidneyofFPN
treatedratswerecomparablewithotherstudiesconducted
onchlorpyrifos[18],malathion[63],methylparathion[64],
fenitrothion [65] and otherinsecticides[66] that reveal
insecticidesareknowntoinduceanumberof
histopatho-logical changesin liverand kidney.Theobservations in
thepreviousmentionedstudiesareincorroborationand
supportourresults.
5. Conclusion
Inviewofthedataofthepresentstudy,itcanbe
sug-gested that FPN induced liver and kidney damage that
corroboratedwiththehistopathologicallesions.FPN
expo-sureproducedmarkedelevationsinLPOandalterationsin
antioxidantbiomarkersinliverandkidneytissues.
There-fore,thechangesinliverandkidneyfunctionscouldbe
due tothegenerationofROS,which causingdamageto
membraneandallcellcomponents.
Conflictofinterest
Nonedeclared.
Transparencydocument
TheTransparencydocumentassociatedwiththisarticle
canbefoundintheonlineversion.
Acknowledgment
TheauthorsthankProf.Dr.KawkabAbdel-Aziz,
Pathol-ogy Department, Faculty of Veterinary Medicine, Cairo
University,Egyptfordemonstratingthehistopathological
slides.
References
[1]USEnvironmentalProtectionAgency,PesticideFactSheet:Fipronil, OfficeofPrevention,Pesticides,andToxicSubstances,Washington, DC,1996.
[2]D. Hainzl,J.E.Casida, Fipronilinsecticide:Novellphotochemical desulfinylationwithretentionofneurotoxicity,Proc.Natl.Acad.Sci. U.S.A.93(1996)12764–12767.
[3]USEnvironmentalProtectionAgency,InterimReregistration Eligi-bilityDecisionforChlorpyrifos.Prevention,PesticidesandToxic Substances,EPA738-R-01-007,Washington,DC,2002.
[4]L.M.Cole,R.A.Nicholson,J.E.Casida,Actionofphenylpyrazole insec-ticidesattheGABA-gatedchloridechannel,Pestic.Biochem.Physiol. 46(1993)47–54.
[5]X.Zhao,V.L.Salgado,J.Z.Yeh,T.Narahashi,Differentialactionsof fipronilanddieldrininsecticidesonGABA-gatedchloridechannels incockroachneurons,J.Pharmacol.Exp.Ther.306(2003)914–924.
[6]R.L.Rose,E.Hodgson,R.M.Roe,Pesticides,in:H.Marquardt,S.G. Schafer,R.McClellan,F.Welsch(Eds.),Toxicology,Academic,San Diego,CA,1999,pp.663–697.
[7]H.Ernest,E.L.Patricia,Classesoftoxicants:useclasses,in:E. Hodg-son,P.E.Levi(Eds.),ATextbookofModernToxicology,2nded., ToxicologyProgramNorthCarolina:AppletonandLange,1997,p. 15.
[8]C.Vidau,R.A.Gonzalez-Polo,M.Niso-Santano,R.Gomez-Sanchez, J.M.Bravo-SanPedro,E.Pizarro-Estrella,R.Blasco,J.Brunet,L.P. Belzunces,J.M.Fuentes,Fipronilisapowerfuluncouplerof oxida-tivephosphorylationthattriggersapoptosisinhumanneuronalcell lineSHSY5Y,Neurotoxicology32(2011)935–943.
[9]P.C.Das,Y.Cao,N.Cherrington,E.Hodgson,R.L.Rose,Fipronilinduces CYPisoformsandcytotoxicityinhumanhepatocytes,Chem.Biol. Interact.164(2006)200–214.
[10]T.L.Lassiter,E.A.MacKillop,I.T.Ryde,F.J.Seidler,T.A.Slotkin,Is fipronilsaferthanchlorpyrifos?Comparativedevelopmental neu-rotoxicitymodeledinPC12cells,BrainRes.Bull.78(2009)313–322.
[11]M.Ohi,P.R.Dalsenter,A.J.Andrade,A.J.Nascimento,Reproductive adverseeffectsoffipronilinWistarrats,Toxicol.Lett.146(2004) 121–127.
[12]K.K.Gill,V.K.Dumka,Antioxidantstatusinoralsubchronictoxicity offipronilandfluorideco-exposureinbuffalocalves,Toxicol.Ind. Health(2013),http://dx.doi.org/10.1177/0748233713500376. [13]B.Clasen,V.L.Loro,R.Cattaneo,B.Moraes,T.Lopes,L.A.Avila,R.
Zanella,G.B.Reimche,B.Baldisserotto,Effectsofthecommercial formulationcontainingfipronilonthenon-targetorganism Cypri-nuscarpio:implicationsforricefishcultivation,Ecotoxicol.Environ. Safety77(2012)45–51.
[14]J.Leghait,V.Gayrard,N.Picard-Hagen,M.Camp,N.Perdu,P.Toutain, C.Viguié,Fipronil-induceddisruptionofthyroidfunction inrats ismediatedbyincreasedtotalandfreethyroxineclearances con-comitantlytoincreasedactivityofhepaticenzymes,Toxicology255 (2009)38–44.
[15]H.T.Fung,K.K.Chan,W.M.Ching,C.W.Kam,Acaseofaccidental ingestionofantbaitcontainingfipronil,J.Toxicol.Clin.Toxicol.41 (2003)245–248.
[16]F.Mohamed,L.Senarathna,A.Percy,M.Abeyewardene,G. Eagle-sham,R.Cheng,S.Azher,A.Hittarage,W.Dissanayake,M.H.Sheriff, W.Davies,N.A.Buckley,M.Eddleston,Acutehumanself-poisoning withtheN-phenylpyrazoleinsecticidefipronil–aGABAA-gated chloridechannelblocker,J.Toxicol.Clin.Toxicol.42(2004)955–963.
[17]S.A. Mansour, A.H. Mossa, Oxidative damage, biochemicaland histopathologicalalterationinratexposedtochlorpyrifosandthe roleofzincasantioxidant,PestBiochem.Physiol.96(2010)14–23.
[18]S.A.Mansour,A.H.Mossa,Lipidperoxidationandoxidativestressin raterythrocytesinducedbychlorpyrifosandtheprotectiveeffectof zinc,PestBiochem.Physiol.93(2009)34–39.
[19]B.D.Banerjee,V.Seth,A.Bhattacharya,S.T.Pasha,A.K.Chakraborty, Biochemicaleffectsofsomepesticidesonlipidperoxidationandfree radicalscavengers,Toxicol.Lett.107(1999)33–47.
[20]K.R.Tukhtaev,S.K.Tulemetov,N.B.Zokirova,N.K.Tukhtaev,M.R. Tillabaev,O.K.Amirullaev,O.O.Yarieva,A.N.Otajonova,Prolonged exposureoflowdosesoffipronilcausesoxidativestressinpregnant ratsandtheiroffspring,Int.J.Toxicol.10(2013)1–11.
[21]WorldHealthOrganization,GuidelinetoWHORecommended Clas-sificationofPesticidesbyHazard,IPCS,1991,pp.39.
[22]Fipronil,Third Reevaluation-Report ofthe HazardIdentification AssessmentReviewCommittee;HEDDoc.No.014400,U.S. Environ-mentalProtectionAgency,HealthEffectsDivision,U.S.Government PrintingOffice,Washington,DC,2000,pp.1–24.
[23]S.Reitman,S.Frankel,Acolorimetricmethodforthedetermination ofserumglutamicoxalaceticandglutamicpyruvictransaminases, Am.J.Clin.Pathol.28(1957)56–63.
[24]D.S.Young,L.C.Pestaner,V.Gibberman,Effectsofdrugsonclinical laboratorytests,Clin.Chem.21(1975)D431–D432.
[25]A.Vassault,Lactatedehydrogenase.UV-methodwithpyruvateand NADH,in:J.Bergmeyer,M.Grabl(Eds.),MethodsofEnzymatic Anal-ysis,Verlag-Chemie,DeerfieldBeach,Florida,1983,pp.119–126.
[26]J.O.Westgard,M.A.Poquette,Determinationofserumalbuminwith the“SMA12-60”byabromocresolgreendye-bindingmethod,Clin. Chem.18(18)(1972)647–653.
[27]N.W.Tietz,E.L.Pruden,O.Siggaard-Andersen,in:C.A.Burtis,E.R. Ashwell(Eds.),TietzTextbookofClinicalChemistry,WBSaunders Company,London,1994,pp.1354–1374.
[28]N.W.Tietz,ClinicalGuidetoLaboratoryTests,3rded.,W.B.Saunders Company,London/Philadelphia,PA,1995,pp.130–131.
[29]M.Nishikimi,N.A.Roa,K.Yogi,Theoccurrenceofsuperoxideanion inthereactionofreducedphenazinemethosulfateandmolecular oxygen,Biochem.Biophys.Res.Commun.46(1972)849–854.
[30]H.Aebi,Catalaseinvitro,MethodsEnzymol.105(1980)121–126.
[31]W.H.Habig,M.J.Pabst,W.B.Jakoby,GlutathioneS-transferases,the firstenzymaticstepinmercapturicacidformation,J.Biol.Chem.249 (1974)7130–7139.
[32]D.E.Paglia,W.N.Valentine,Studiesonthequantitativeand quali-tativecharacterizationoferythrocyteglutathioneperoxidase,J.Lab. Clin.Med.70(1967)158–169.
[33]E.Beutler,O.Duron,B.M.Kelly,Improvedmethodforthe determi-nationofbloodglutathione,J.Lab.Clin.Med.61(1963)882–888.
[34]K.Satoh,Serumlipidperoxideincerebrovasculardisorders deter-minedbyanewcolorimetricmethod,Clin.Chim.Acta15(1978) 37–43.
[35]O.H.Lowry,N.J.Rosebrough,A.L.Farr,R.J.Randall,Protein mea-surementwiththeFolinphenolreagent,J.Biol.Chem.193(1951) 265–275.
[36]J.D.Michael,TheToxicologist’sPocketHandbook,2nded.,Informa HealthcareUSA,Inc.,NewYork,2008,pp.44.
[37]S.Mondot,M.Dange,AcuteoralLD50inthemouse,in:Unpublished reportNo.R&D/CRSA/TO-PHA3 from Rhone-Poulenc Agrochimie Toxicology(ResearchTrianglePark,NC,USA,SubmittedtoWHOby Rhone-Poulenc,Inc.),1995.
[38]D.Ray,Reportofthetoxicityoffipronil,in:UnpublishedReportfrom MedicalResearchCouncil(Leicester,UnitedKingdom,Submittedto WHObyMRCToxicology),1997.
[39]A.H.Mossa,M.A.Abbassy,Adversehaematologicalandbiochemical effectsofcertainformulatedinsecticidesinmalerats,Res.J.Environ. Toxicol.6(2012)160–168.
[40]USEnvironmentalProtectionAgency,DataEvaluationReport: Com-binedchronictoxicity/oncogenicity/rats.ReviewedbyVirginiaA. Dobozy.ToxicologyBranchII.MRIDNo.429186-48.May12,1994.
[41]A.Seven,S.Güzel,O.Seymen,S.Civelek,M.Bolayirh,M.Uncu,G. BurC¸ak,EffectsofvitaminEsupplementationonoxidativestress instreptozotocininduceddiabeticrats:investigationofliverand plasma,YonseiMed.J.45(2004)703–710.
[42]N.M.Aly,R.K.Abou-El-khear,A.S.El-Bakary,Immunological, haema-tologicalstudiesonalbinoratstreatedwithwarfarin,J.Alex.Sci. Exch.18(1997)265–275.
[43]C.Harper,Wernicke’sencephalopathy:amorecommondiseasethan realised.Aneuropathologicalstudyof51cases,J.Neurol.Neurosurg. Psychiatry42(1979)226–231.
[44]M.E.Awad,M.S.Abdel-Rahman,S.A.Hassan,Acrylamidetoxicityin isolatedrathepatocytes,Toxicol.InVitro12(1998)699–704.
[45]A.Goel,V.Dani,D.K.Dhawan,Protectiveeffectsofzinconlipid peroxidation,antioxidantenzymesandhepatichistoarchitecture inchlorpyrifos-inducedtoxicity,Chem.Biol.Interact.156(2005) 131–140.
[46]A.K.Ola,H.S.Sandhu,B.Ranjan,V.K.Dumka,Fipronil-induced bio-chemicalalterationsduringoralsubacutetoxicityinbuffalocalves, Proc.Natl.Acad.Sci.IndiaB:Biol.Sci.83(2013)539–544.
[47]A.H.El-Sebae,E.E.Enan,S.A.El-Fiki,E.Khamees,Biochemicaleffects ofsomeorganophosphorusinsecticidesonnewtargetsinwhiterats, J.Environ.Sci.HealthB16(1981)475–491.
[48]A.H.Mossa,A.A.Refaie,A.Ramadan,J.Bouajila,Ameliorationof prallethrin-inducedoxidativestressandhepatotoxicityinratbythe administrationofOriganummajoranaessentialoil,BioMedRes.Int. 2013(2013)1–11.
[49]A.H.Mossa,A.A.Refaie,A.Ramadan,Effectofexposuretomixture offourorganophosphateinsecticidesatnoobservedadverseeffect level(NOAEL)doseonratliver:theprotectiveroleofvitaminC,Res. J.Environ.Toxicol.5(2011)323–335.
[50]J.P.Kassirer,Clinicalevaluationofkidneyfunction,N.Engl.J.Med. 285(1971)385–389.
[51]C.C.Tingle,J.A.Rother,C.F.Dewhurst,S.Lauer,W.J.King,Fipronil: environmentalfate,ecotoxicology,andhumanhealthconcerns,Rev. Environ.Contam.Toxicol.176(2003)1–66.
[52]D.Sharma,G.K.Sangha,Triazophosinducedoxidativestressand his-tomorphologicalchangesinliverandkidneyoffemalealbinorats, Pestic.Biochem.Physiol.110(2014)71–80.
[53]A.M.Al-Othman,K.S.Al-Numair,G.E.El-Desoky,K.Yusuf,Z.A. Al-Othman,M.A.M.Aboul-Soud,J.P.Giesy,Protectionof␣-tocopherol andseleniumagainstacuteeffectsofmalathiononliverandkidney ofrats,Afr.J.Pharm.Pharmacol.5(2011)1263–1271.
[54]S.A. Kelly, K.M. Harvilla, T.C. Brady, K.H. Abrano, E.D. Leveir, Oxidativestressintoxicology:establishedmammalianand emerg-ingpiscinemodelsystems,Environ.HealthPerspect.106(1998) 375–384.
[55]J.P.Kehrer,Freeradicalasmediatoroftissueinjuryanddisease,Crit. Rev.Toxicol.23(1993)21–48.
[56]M.Abdollahi,A.Ranjbar,S.Shadnia,S.Nikfar,A.Rezaie,Pesticidesand oxidativestress:areview,Med.Sci.Monit.10(2004)RA141–RA147.
[57]F.Peixoto,J.Vicente,V.M.C.Madeira,Acomparativestudyofplant andanimalmitochondriaexposedtoparaquatrevealsthathydrogen peroxideisnotrelatedtotheobservedtoxicity,Toxicol.InVitro18 (2004)733–739.
[58]N.S.El-Shenawy,F.El-Salmy,R.A.Al-Eisa,B.El-Ahmary,Amelioratory effect of vitamin Eon organophosphorus insecticide diazinon-inducedoxidativestressinmiceliver,Pestic.Biochem.Physiol.96 (2010)101–107.
[59]Y.W.Ki,J.E.Lee,J.H.Park,I.C.Shin,H.C.Koh,Reactiveoxygenspecies andmitogen-activatedproteinkinaseinduceapoptoticdeathof SH-SY5Ycellsinresponsetofipronil,Toxicol.Lett.211(2012)18–28.
[60]T.C.SMargarido,A.A.Felício,D.C.Rossa-Feres,E.A.deAlmeida, Bio-chemicalbiomarkersinScinaxfuscovariustadpolesexposedtoa commercialformulationofthepesticidefipronil,Mar.Environ.Res. 91(2013)61–67.
[61]I.Kostaropoulos,A.I.Papadopoulos,A.Metaxakis,E.Boukouvala,E. Papadopoulou-Mourkidou,GlutathioneS-transferaseinthedefense againstpyrethroidsininsects,Insect.Biochem.Mol.Biol.31(2001) 313–319.
[62]J.L.Bolton,M.Chang,Quinoidsasreactiveintermediatesinestrogen carcinogenesis,Adv.Exp.Med.Biol.500(2001)497–507.
[63]J.T.Bolton,M.A.Trush,T.M.Penning,G.Dryhurst,T.J.Monks,Roleof quinonesintoxicology,Chem.Res.Toxicol.13(2000)135–160.
[64]G.El-Desoky,M.Abdelreheem,A.AL-Othman,Z.AL-Othman,M. Mahmoud,K.Yusuf,PotentialhepatoprotectiveeffectsofvitaminE andseleniumonhepatotoxicityinducedbymalathioninrats,Afr.J. Pharm.Pharmacol.6(2012)806–813.
[65]S.Kalender,Y.Kalender,D.Durak,A.Ogutcu,M.Uzunhisarcikli,B.S. Cevrimli,M.Yildirim,Methylparathioninducednephrotoxicityin maleratsandprotectiveroleofvitaminsCandE,Pestic.Biochem. Physiol.88(2007)213–218.
[66]S.B. Budin, K.J. Han, P.A. Jayusman, I.S. Taib, A.R. Ghazali, J. Mohamed,Antioxidantactivityoftocotrienolrichfractionprevents fenitrothion-induced renaldamageinrats,J. Toxicol.Pathol.26 (2013)111–118.